Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 May;117(5):998-1004.e6.
doi: 10.1016/j.ophtha.2009.10.014. Epub 2010 Feb 16.

A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children

Affiliations
Randomized Controlled Trial

A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children

Pediatric Eye Disease Investigator Group Writing Committee et al. Ophthalmology. 2010 May.

Abstract

Objective: To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia.

Design: Randomized, clinical trial.

Participants: We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40-20/80).

Methods: Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks.

Main outcome measures: Visual acuity in amblyopic eyes at 24 weeks.

Results: At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved > or =3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had > or =20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement.

Conclusions: Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Visit Completion by Treatment Group
Flow chart showing study completion in each treatment group.
Figure 2
Figure 2. Cumulative Distribution of Visual Acuity at 24-week Masked Exam
Cumulative distribution of amblyopic eye visual acuity scores at 24-week outcome exam according to treatment group.
Figure 3
Figure 3. Mean Visual Acuity in Amblyopic Eyes from Baseline to 24 Weeks
At each time point, the box on the left is the distribution of amblyopic eye visual acuity scores for the Bangerter group and the one on the right represents the patching group. The top and bottom of each box represents the 25th and 75th percentiles of the data and the line in the box is the median. The treatment group means are represented by a dot (Bangerter) or a square (patching) and are connected across the visits with lines. The bars extending above and below each box represent 1.5 times the interquartile range (difference between the 25th and 75th percentiles), and the open circles are outlier values.

References

    1. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268–78. - PubMed
    1. Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol. 2008;126:1634–42. - PMC - PubMed
    1. Pediatric Eye Disease Investigator Group. Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial. Arch Ophthalmol. 2009;127:22–30. - PMC - PubMed
    1. Bangerter A. Occlusion in pleoptics and orthoptics [in German] Klin Monatsblatter Augenheilkd Augenarztl Fortbild. 1960;136:305–31. - PubMed
    1. Lang J. An efficient treatment and new criteria for cure of strabismic amblyopia: reading and Bangerter foils. Binocul Vis Strabismus Q. 1999;14:9–10. - PubMed

Publication types